Proteins, not genes, are the true targets of medicines, but their analysis by array technology still poses significant challenges for drug developers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
© Bob Crimi
References
MacBeath, G. & Schreiber, S. Printing proteins as microarrays for high-throughput function determination. Science 289, 1760–1763 (2000).
Karlstrom, A. & Nygren, P. Dual labeling of a binding protein allows for specific fluorescence detection of native protein. Anal. Biochem. 295, 22–30 (2001).
Heng, Z. et al. Global analysis of protein activities using proteome chips. Science 293, 2101–2105 (2001).
Sabatini, D. & Ziauddin, J. Microarrays of cells expressing defined cDNA. Nature 411, 107–110 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitchell, P. A perspective on protein microarrays. Nat Biotechnol 20, 225–229 (2002). https://doi.org/10.1038/nbt0302-225
Issue Date:
DOI: https://doi.org/10.1038/nbt0302-225
